Filing Details
- Accession Number:
- 0001104659-20-012390
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-07 12:58:14
- Reporting Period:
- 2019-12-19
- Accepted Time:
- 2020-02-07 12:58:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1138776 | Aevi Genomic Medicine Inc. | GNMX | Pharmaceutical Preparations (2834) | 1231 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 901832 | Plc Astrazeneca | 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge X0 CB2 0AA | No | No | Yes | No | |
| 1790714 | Ltd Medimmune | 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge X0 CB2 0AA | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-19 | 12,946,900 | $0.00 | 12,946,900 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnote |
Footnotes
- All of these securities were issued to MedImmune Limited in satisfaction of the Issuer's obligations to MedImmune Limited pursuant to the Option and License Agreement, dated August 6, 2019, between the Issuer and MedImmune Limited.
- All of these securities are owned by MedImmune Limited, which is a wholly-owned subsidiary of AstraZeneca PLC. AstraZeneca PLC may be deemed to beneficially own the shares held by MedImmune Limited, but disclaims beneficial ownership except to the extent of its pecuniary interest therein, if any.
Billionaire Hedge Funds
